Soligenix (SNGX) Competitors $2.95 -0.13 (-4.22%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SNGX vs. RNXT, PMN, LIAN, NXTC, KALA, DRRX, FBRX, DARE, LGVN, and LPCNShould you be buying Soligenix stock or one of its competitors? The main competitors of Soligenix include RenovoRx (RNXT), ProMIS Neurosciences (PMN), LianBio (LIAN), NextCure (NXTC), KALA BIO (KALA), DURECT (DRRX), Forte Biosciences (FBRX), Daré Bioscience (DARE), Longeveron (LGVN), and Lipocine (LPCN). These companies are all part of the "pharmaceutical products" industry. Soligenix vs. RenovoRx ProMIS Neurosciences LianBio NextCure KALA BIO DURECT Forte Biosciences Daré Bioscience Longeveron Lipocine Soligenix (NASDAQ:SNGX) and RenovoRx (NASDAQ:RNXT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, community ranking, earnings, valuation and media sentiment. Does the media refer more to SNGX or RNXT? In the previous week, Soligenix had 5 more articles in the media than RenovoRx. MarketBeat recorded 5 mentions for Soligenix and 0 mentions for RenovoRx. Soligenix's average media sentiment score of 0.00 equaled RenovoRx'saverage media sentiment score. Company Overall Sentiment Soligenix Neutral RenovoRx Neutral Do insiders & institutionals have more ownership in SNGX or RNXT? 3.6% of Soligenix shares are held by institutional investors. Comparatively, 3.1% of RenovoRx shares are held by institutional investors. 2.8% of Soligenix shares are held by insiders. Comparatively, 7.1% of RenovoRx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts recommend SNGX or RNXT? RenovoRx has a consensus price target of $6.50, suggesting a potential upside of 420.00%. Given RenovoRx's stronger consensus rating and higher probable upside, analysts plainly believe RenovoRx is more favorable than Soligenix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Soligenix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00RenovoRx 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, SNGX or RNXT? Soligenix has a beta of 1.79, indicating that its stock price is 79% more volatile than the S&P 500. Comparatively, RenovoRx has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Which has stronger earnings & valuation, SNGX or RNXT? Soligenix has higher revenue and earnings than RenovoRx. RenovoRx is trading at a lower price-to-earnings ratio than Soligenix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSoligenix$840K8.81-$6.14M-$7.53-0.39RenovoRxN/AN/A-$10.23M-$0.57-2.19 Is SNGX or RNXT more profitable? RenovoRx has a net margin of 0.00% compared to Soligenix's net margin of -1,473.38%. RenovoRx's return on equity of -205.96% beat Soligenix's return on equity.Company Net Margins Return on Equity Return on Assets Soligenix-1,473.38% -223.29% -74.18% RenovoRx N/A -205.96%-110.01% Does the MarketBeat Community favor SNGX or RNXT? Soligenix received 269 more outperform votes than RenovoRx when rated by MarketBeat users. Likewise, 72.97% of users gave Soligenix an outperform vote while only 47.37% of users gave RenovoRx an outperform vote. CompanyUnderperformOutperformSoligenixOutperform Votes27872.97% Underperform Votes10327.03% RenovoRxOutperform Votes947.37% Underperform Votes1052.63% SummarySoligenix beats RenovoRx on 9 of the 16 factors compared between the two stocks. Ad Crypto 101 MediaThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Soligenix News Delivered to You Automatically Sign up to receive the latest news and ratings for SNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNGX vs. The Competition Export to ExcelMetricSoligenixPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.40M$6.57B$5.12B$9.07BDividend YieldN/A2.98%4.91%4.22%P/E Ratio-0.3910.5991.3417.19Price / Sales8.81195.381,116.59116.80Price / CashN/A57.1642.6437.86Price / Book0.775.104.794.78Net Income-$6.14M$151.51M$120.07M$225.60M7 Day Performance-6.65%-2.15%-1.89%-1.24%1 Month Performance-12.98%-3.14%11.45%3.36%1 Year Performance-69.61%11.50%30.61%16.58% Soligenix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNGXSoligenix0.7359 of 5 stars$2.95-4.2%N/A-67.4%$7.40M$840,000.00-0.3920Positive NewsGap UpRNXTRenovoRx1.24 of 5 stars$1.27-1.1%$6.50+413.5%+76.1%$30.38MN/A-2.256Positive NewsGap UpPMNProMIS Neurosciences1.0717 of 5 stars$0.91-2.7%N/A-20.2%$29.58M$10,000.00-9.306Positive NewsLIANLianBioN/A$0.27flat$3.50+1,194.4%-94.2%$29.22MN/A-0.33110NXTCNextCure4.2168 of 5 stars$1.02-5.6%$4.00+292.2%-14.9%$28.57MN/A-0.5290Positive NewsKALAKALA BIO3.8466 of 5 stars$6.17-0.2%$15.00+143.1%-13.3%$28.44M$3.89M-0.5030Gap DownDRRXDURECT2.6267 of 5 stars$0.91+21.4%$5.00+449.2%+89.2%$28.26M$8.59M-1.3980Analyst ForecastNews CoverageFBRXForte Biosciences1.6829 of 5 stars$19.05-17.7%$23.58+23.8%+65,237.8%$27.81MN/A-1.315DAREDaré Bioscience1.5891 of 5 stars$3.18flat$24.00+654.7%-31.1%$27.67M$1.88M-5.3930Analyst ForecastGap DownLGVNLongeveron3.4381 of 5 stars$1.85-0.8%$8.67+369.7%-89.8%$27.37M$1.89M-0.3023LPCNLipocine1.531 of 5 stars$4.96-1.2%$10.00+101.6%+63.4%$26.53M$7.92M-6.6110News Coverage Related Companies and Tools Related Companies RenovoRx Competitors ProMIS Neurosciences Competitors LianBio Competitors NextCure Competitors KALA BIO Competitors DURECT Competitors Forte Biosciences Competitors Daré Bioscience Competitors Longeveron Competitors Lipocine Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SNGX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soligenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soligenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNGX Stock Alerts